| Metric | Q3-26 | Q3-25 |
|---|---|---|
| Revenue | 311.01 | 364.21 |
| Gross Profit | 202.17 | 256.72 |
| Pretax Income | 1.89 | 15.99 |
| Net Income | -0.74 | 17.08 |
| Diluted EPS | -0.02 | 0.34 |
- Net Income YoY
- -104.3%
Key highlights
- Quarterly revenue decreased to $311.01 million from $364.21 million in the prior year period
- Net income fell 104.3% year-over-year to a loss of $0.74 million
- Nine-month net loss reached $248.7 million, including a $190.0 million income tax provision
- Impairment expenses of $80.7 million weighed heavily on the year-to-date results
- Management projected full-year 2026 revenue between $1,260 million and $1,290 million
How the Period Went
Nu Skin Enterprises experienced a contraction in its third-quarter performance, with revenue falling to $311.01 million compared to $364.21 million in Q3 2025. This decline in top-line activity resulted in a gross profit of $202.17 million, down from $256.72 million a year earlier. The pressure on the company's operating structure was evident as pretax income narrowed significantly to $1.89 million from $15.99 million. The period ultimately concluded with a net loss of $0.74 million, a sharp reversal from the $17.08 million profit reported in the prior year, marking a 104.3% year-over-year decrease in net earnings.
Margins and Profitability
- Diluted earnings per share shifted to a loss of $0.02, down from a $0.34 profit in the previous year
- Year-to-date net loss was primarily driven by a non-recurring $190.0 million provision for income taxes
- Total impairment expenses of $80.7 million further impacted the cumulative nine-month profitability
- Gross profit margins remained under pressure as revenue saw a sequential decline from $320.1 million in Q2 2026
- The board declared a quarterly cash dividend of $0.06 per share, maintaining shareholder payouts despite the net loss
Business Overview
Nu Skin Enterprises is a global personal care and wellness company that operates through a direct-to-consumer and brand affiliate model. Based in the United States and listed on the NYSE, the company focuses on the development and distribution of premium beauty and nutritional products within the consumer defensive sector. According to Nature's Sunshine investor data, Nu Skin does not maintain a traditional order backlog, instead relying on its network of independent affiliates to drive real-time sales and market penetration. The business is currently navigating a challenging operating environment characterized by shifting consumer demand across its core international segments.
Financial Context
The Q3 results arrive amidst a broader downward trend for the stock, which has seen a 13.93% price decline over the current quarter. With a market capitalization of $220.51 million, Nu Skin is trading at a significant discount relative to its annual revenue of $1.48 billion reported in 2025. Market data shows a daily price drop of 9.22%, coinciding with the earnings release. Management guidance provided via StockTitan suggests full-year 2026 revenue will range between $1,260 million and $1,290 million, with fourth-quarter expectations set between $310 million and $340 million, indicating a stabilization of current revenue levels.
Down 13.2% since our story on 6 Nov: $4.53 when we broke it → $3.93 at the close on 16 Nov. Daily closing prices. Source: Yahoo Finance.
Show the prices
| 19 Oct | $4.97 |
|---|---|
| 20 Oct | $4.98 |
| 21 Oct | $4.76 |
| 22 Oct | $4.92 |
| 23 Oct | $4.79 |
| 26 Oct | $4.69 |
| 27 Oct | $4.73 |
| 28 Oct | $4.76 |
| 29 Oct | $4.69 |
| 30 Oct | $4.65 |
| 2 Nov | $4.78 |
| 3 Nov | $4.70 |
| 4 Nov | $4.99 |
| 5 Nov | $4.53 |
| 6 Nov | $4.10 |
| 9 Nov | $4.28 |
| 10 Nov | $4.03 |
| 11 Nov | $3.89 |
| 12 Nov | $4.01 |
| 13 Nov | $4.03 |
| 16 Nov | $3.93 |
Industry Landscape
Operating within the household and personal products industry, Nu Skin faces stiff competition from both traditional retail brands and other direct-selling organizations. The sector has been impacted by rising costs and a cautious consumer environment, which has pressured margins across the beauty and wellness space. Nu Skin's performance reflects these headwinds, particularly regarding the impact of international tax provisions and non-cash impairment charges. While the company maintains a dividend of $0.06 per share, its 9-month net loss of $248.7 million highlights the fiscal volatility currently affecting specialized personal care firms as they attempt to restructure for long-term stability.
| Date | Announcement | Amount |
|---|---|---|
| 05 Nov 2026 | Q3 2026 revenueSource: gurufocus.com | $311.0 Million |
| 10 Aug 2026 | Q2 2026 revenueSource: ir.nuskin.com | $320.1 Million |
| 07 May 2026 | Q1 2026 revenueSource: SEC filing | $320.6 Million |
| 12 Feb 2026 | Q4 2025 revenueSource: SEC filing | $370.3 Million |
| 06 Nov 2025 | Q3 2025 revenueSource: nasdaq.com | $364.2 Million |
| 07 Aug 2025 | Q2 2025 revenueSource: nuskin.com | $386.1 Million |
| Share price | $4.53 |
|---|---|
| Market cap | $221M |
| Revenue (annual) | $1.5B |
| 1-month price change | -4.43% |
| Sector | Consumer DefensiveHousehold & Personal Products |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
SEC filing by Nu Skin Enterprises, Inc. announcing its third quarter 2026 financial results.
Track NU SKIN ENTERPRISES, INC. live
Get the next NU SKIN ENTERPRISES, INC. SEC filing seconds after it lands.



